Epinephrine given to non-inbred male albino rats in a pharmacological dose of 1 mg/kg was studied for effects on their serum complement. Following 5 min of its administration, the complement activity both of blood overall and individual parameters reduced by 0.4-0.7 log2 as compared with the baseline, 20 minutes after it significantly increased up to 0.5 log 2 as compared with the baseline titer, and returned to the baseline level 2 hours later. Following 24 hours of epinephrine administration, complement activity again increased, by reaching its peak on days 2 and 3 of the experiment and accounting for 1.5-2.0 log2 as compared with the baseline titer. The alpha-adrenoblocker tropaphen did not affect the epinephrine-induced suppression of complement activity 5 minutes after its use and enhanced the mediated effect of the complement activity growth-associated hormone on days 2 and 3 of the experiment. Blockade with the beta-adrenoreceptor inderal virtually failed to affect the complement-mediated action on epinephrine on days 2 and 3 of its use.

Download full-text PDF

Source

Publication Analysis

Top Keywords

complement activity
16
compared baseline
12
activity blood
8
administration complement
8
log2 compared
8
baseline titer
8
days experiment
8
complement
6
activity
5
[change functional
4

Similar Publications

Analysis of the effect of ALA-PDT on macrophages in footpad model of mice infected with based on single-cell sequencing.

Open Med (Wars)

January 2025

Department of Dermatology and Venereology, The Third Affiliated Hospital, Southern Medical University, 183 West Zhongshan Road, Guangzhou, China.

Chromoblastomycosis (CBM) is a chronic neglected fungal disease that causes serious damage to the physical and mental health of patients. 5-Aminolevulinic acid photodynamic therapy (ALA-PDT) has garnered significant attention in the recent era for the treatment of CBM and has exhibited promising effects in several clinical case reports. We established a mice footpad infection model with and analyzed the impact of PDT treatment on the immune response of macrophages using single-cell sequencing.

View Article and Find Full Text PDF

Objective: To evaluate the efficacy of double filtration plasmapheresis combined with immunosuppressive agents in the treatment of severe lupus nephritis.

Method: A retrospective analysis was conducted on the medical records of 102 cases of severe lupus nephritis treated between January 2021 and December 2022 in the General Practice Department at the Affiliated Hospital of North Sichuan Medical College. Patients who received immunosuppressive agents were included in the control group and those who received additional double filtration plasmapheresis were included in the observation group.

View Article and Find Full Text PDF

Introduction The internet age has broadened the horizons of modern medicine, and the ever-increasing scope of artificial intelligence (AI) has made information about healthcare, common pathologies, and available treatment options much more accessible to the wider population. Patient autonomy relies on clear, accurate, and user-friendly information to give informed consent to an intervention. Our paper aims to outline the quality, readability, and accuracy of readily available information produced by AI relating to common foot and ankle procedures.

View Article and Find Full Text PDF

Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disease that causes recurrent neuritis and myelitis. Ravulizumab, a complement protein C5 inhibitor, was developed to treat NMOSD. However, its efficacy in improving symptoms remains unclear.

View Article and Find Full Text PDF

This investigation looked at the ameliorative role of camel whey protein hydrolysates-diet (PH) in Oreochromis niloticus stocked under alkaline conditions. One hundred sixty fish (16.02 ± 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!